|
2024
|
Invention
|
Improved anti-cancer treatment regimen. The present invention relates to treatment regimens for i... |
|
2023
|
Invention
|
Salts of sco-101 and methods involving salts. The present invention describes salts of SCO-101, c... |
|
|
Invention
|
Abcg2 inhibitor and nae inhibitor for the treatment of cancer. The present invention relates to t... |
|
2022
|
Invention
|
Combination of drugs for the treatment of cancer. The present invention relates to methods for tr... |
|
|
Invention
|
Thermodynamically stable form of sco-101.
The present invention relates to an improved crystal f... |
|
|
Invention
|
Thermodynamically stable form of sco-101. The present invention relates to an improved crystal fo... |
|
|
G/S
|
Active chemical ingredients for use in the manufacture of anti-cancer drugs Anti-cancer preparati... |
|
|
G/S
|
Active chemical ingredients for use in the manufacture of anti-cancer drugs. Anti-cancer preparat... |
|
|
Invention
|
Methods of increasing the plasma drug exposure of anticancer agents.
The present invention relat... |
|
|
Invention
|
Combination treatments for cancer patients and methods for identifying same.
The present inventi... |
|
|
Invention
|
Methods of increasing the plasma drug exposure of anticancer agents. The present invention relate... |
|
|
Invention
|
Combination treatments for cancer patients and methods for identifying same. The present inventio... |
|
2021
|
Invention
|
Combination treatment of cancer. The present invention relates to treatment of cancer, in particu... |
|
2019
|
Invention
|
Compounds for treatment of microbial infection. The present invention relates to treatment, ameli... |
|
|
Invention
|
Urea derivatives for use in the treatment of subjects with elevated expression and/or activity of... |
|
2016
|
Invention
|
4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as bcrp inhibitors in... |
|
2012
|
Invention
|
4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and their ... |
